DBV Technologies | DBVT - Umsatzerlöse





Der Umsatz Veränderung Datum
Acadia Pharmaceuticals USD 268.06M 15.94M 2026-03
Alnylam Pharmaceuticals USD 1.17B 70M 2026-03
Amarin USD 49.22M 451K 2025-12
BioCryst Pharmaceuticals USD 406.56M 247.16M 2025-12
BioMarin Pharmaceutical USD 766M 109M 2026-03
DBV Technologies USD 645K 2.13M 2025-12
Esperion Therapeutics USD 168.45M 81.14M 2025-12
Halozyme Therapeutics USD 377M 74.76M 2026-03
Incyte USD 1.27B 240M 2026-03
Insmed USD 305.96M 42.16M 2026-03
Ionis Pharmaceuticals USD 246M 43M 2026-03
Neurocrine Biosciences USD 811M 5.5M 2026-03
PTC Therapeutics USD 273M 108.3M 2026-03
Sarepta Therapeutics USD 730.8M 287.9M 2026-03
Ultragenyx Pharmaceutical USD 136M 71M 2026-03
United Therapeutics USD 781.5M 8.7M 2026-03